Drug Profile
Epoetin alfa biosimilar - Intas BioPharmaceuticals
Alternative Names: Epofit; Erykine; RenocelLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Intas Biopharmaceuticals
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 31 Aug 2005 Launched for Anaemia in India (IV)
- 31 Aug 2005 Launched for Anaemia in India (SC)